Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms. One is raising flags among 340B providers and the other appears to be the first of its kind and may be welcomed by covered entities.
The company requires health centers, disproportionate share hospitals, critical access hospitals, rural referral centers, and sole community hospitals that wish to dispense 340B-purchased Sanofi drugs at more than one contract pharmacy to submit claims data to Sanofi’s third-party vendor 340B ESP for those products filled by those pharmacies. If an affected entity declines to provide the data and lacks an in-house pharmacy, it can designate a single contract pharmacy to dispense 340B-purchased Sanofi drugs.
Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
